Envoy Medical (COCHW) Net Cash Flow (2021 - 2026)

Envoy Medical has disclosed Net Cash Flow across 6 years of filings, most recently posting $21.5 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $21.5 million, up 12254.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.9 million (up 5378.85% YoY), and the FY2025 annual result was -$1.7 million, down 237.67% from the prior year.
• Net Cash Flow came in at $21.5 million for Q1 2026 at Envoy Medical, up from $183000.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $21.5 million in Q1 2026 to a low of -$12.6 million in Q4 2023.
• The 5-year median for Net Cash Flow is -$22740.0 (2022), against an average of $1.4 million.
• Across the five-year window, Net Cash Flow tumbled 2904.76% in 2023 and soared 12254.24% in 2026, its largest moves.
• Envoy Medical's Net Cash Flow stood at -$420000.0 in 2022, then sank by 2904.76% to -$12.6 million in 2023, then surged by 108.4% to $1.1 million in 2024, then plunged by 82.74% to $183000.0 in 2025, then jumped by 11655.74% to $21.5 million in 2026.
• The last three Net Cash Flow figures came in at $21.5 million (Q1 2026), $183000.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.